Total planned funding: $32,918,817
Allocations
Countries/Regions
| Central Asia Region | $32,918,817 |
Organizational Types
| Own Agency | $10,348,112 |
| NGO | $6,070,994 |
| University | $5,303,877 |
| Host Country Government Agency | $4,136,266 |
| Unknown | $3,032,339 |
| Private Contractor | $2,882,129 |
| Multi-lateral Agency | $920,000 |
| Implementing Agency | $167,000 |
| Other USG Agency | $58,100 |
Program Areas
| Prevention | $10,121,231 |
| Management and Operations | $8,815,255 |
| Governance and Systems | $7,730,292 |
| Care | $2,780,013 |
| Treatment | $2,103,906 |
| Testing | $1,368,120 |
Budget Codes
| HVMS: Management and Operations | $8,815,255 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,089,388 |
| HLAB: Laboratory Infrastructure | $2,949,969 |
| OHSS: Health Systems Strengthening | $2,773,752 |
| HBHC: Care: Adult Care and Support | $2,700,237 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $2,245,859 |
| HTXS: Treatment: Adult Treatment | $2,077,886 |
| HVSI: Strategic Information | $2,006,571 |
| HVCT: Testing: HIV Testing and Counseling | $1,368,120 |
| HMBL: Biomedical Prevention: Blood Safety | $526,818 |
| HMIN: Biomedical Prevention: Injection Safety | $259,166 |
| HVTB: Care: TB/HIV | $79,776 |
| HTXD: Treatment: ARV Drugs | $26,020 |
Top Partner Programs
USG Aggregated Agencies:
$10,348,112
Countries/Regions
Central Asia Region
| 2011 | $5,099,999 |
| 2012 | $1,121,824 |
| 2016 | $4,126,289 |
Columbia University:
$5,303,877
Countries/Regions
Central Asia Region
| 2011 | $927,743 |
| 2012 | $979,042 |
| 2016 | $3,397,092 |
Population Services International:
$3,310,994
Countries/Regions
Central Asia Region
| 2011 | $3,310,994 |
| 2012 | $0 |
| 2016 | $0 |
Not Available:
$3,032,339
Countries/Regions
Central Asia Region
| 2011 | $1,092,788 |
| 2012 | $1,913,199 |
| 2016 | $26,352 |
Ministry of Health - Central Asia Region:
$2,425,620
Countries/Regions
Central Asia Region
| 2011 | $2,425,620 |